Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129020) titled 'Bevacizumab as Monotherapy or Combination Therapy for Treatment of Ovarian Cancer:A Single-Center, Real-World Study' on July 29.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The affiliated hospital of southwest medical university
Condition:
Histologically confirmed epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Observation group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=329255...